Alternative splicing variants of human Fbx4 disturb cyclin D1 proteolysis in human cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Alternative splicing variants of human Fbx4 disturb cyclin D1 proteolysis in human cancer

Published:2014-04 Issue:1 Volume:447 Page:158-164
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Chu Xiufeng,Zhang Ting,Wang Jie,Li Meng,Zhang Xiaolei,Tu Jing,Sun Shiqin,Chen Xiangmei,Lu Fengmin

Funder

National Natural Science Foundation of China

Doctoral Fund of Ministry of Education of China

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference22 articles.

1. SCF and Cullin/Ring H2-based ubiquitin ligases;Deshaies;Annu. Rev. Cell Dev. Biol.,1999

2. Mechanisms underlying ubiquitination;Pickart;Annu. Rev. Biochem.,2001

3. Control of cell growth by the SCF and APC/C ubiquitin ligases;Skaar;Curr. Opin. Cell Biol.,2009

4. The F-box protein FBX4 targets PIN2/TRF1 for ubiquitin-mediated degradation and regulates telomere maintenance;Lee;J. Biol. Chem.,2006

5. Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-alphaB crystallin) complex;Lin;Mol. Cell,2006

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The E3 Ubiquitin Ligase Fbxo4 Functions as a Tumor Suppressor: Its Biological Importance and Therapeutic Perspectives;Cancers;2022-04-25

2. Identification and Validation of Hub Genes in Acute Pancreatitis and Hypertriglyceridemia;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2022-02

3. Cyclin D degradation by E3 ligases in cancer progression and treatment;Seminars in Cancer Biology;2020-12

4. Study on the Differential Analysis of Alternative Splicing Based on the Median Value Jensen-Shannon Divergence;J ELECTRON INF TECHN;2020

5. MicroRNA-561 Affects Proliferation and Cell Cycle Transition Through PTEN/AKT Signaling Pathway by Targeting P-REX2a in NSCLC;Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics;2020-03-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3